Viiv Healthcare Release Date

Listing Websites about Viiv Healthcare Release Date

Filter Type:

ViiV Healthcare Announces US FDA Approval of - Business Wire

(Just Now) People also askWho owns ViiV Healthcare?ViiV Healthcare announces US FDA appr ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug Administration (FDA) has approved Rukobia (fostemsavir), 600 mg extended-release tablets.ViiV Healthcare announces US FDA approval for Rukobia (fostemsavir), a us.gsk.comWhat's new at ViiV Healthcare?Kimberly Smith, M.D., MPH, Head of Research & Development at ViiV Healthcare, said: "As leaders in developing long-acting injectables for the treatment of HIV, we’re excited to present new data setting the stage for ViiV’s next generation of medicines and demonstrating how key pipeline assets will target HIV in different ways.ViiV Healthcare to present data for its next generation of ultra long finance.yahoo.comWhat is ViiV Healthcare's market share?ViiV Healthcare's products have a market share of approximately 32% of the global HIV therapy market, making it the second-largest healthcare company in the sector, after Gilead Sciences.ViiV Healthcare - Wikipediaen.wikipedia.orgWhat is ViiV Healthcare?Through its paediatric voluntary licences, ViiV Healthcare enables generic versions of dolutegravir to be manufactured and sold royalty-free for the treatment of children living with HIV in all least-developed, low-income, lower-middle-income and sub-Saharan Africa countries, as well as some upper-middle-income countries.ViiV Healthcare announces US FDA approval of Triumeq PD, the first us.gsk.comFeedbackViiV Healthcarehttps://viivhealthcare.com/en-us/media-center/news/LATITUDE phase III interim trial data indicates ViiV Healthcare’s …WebLondon, 21 February 2024 – ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced results from an interim analysis of the LATITUDE phase III trial, indicating their long …

https://www.businesswire.com/news/home/20220329005875/en/ViiV-Healthcare-Announces-US-FDA-Approval-of-Cabenuva-cabotegravir-rilpivirine-for-Virologically-Suppressed-Adolescents-Living-With-HIV-Who-Are-12-Years-of-Age-or-Older-and-Weigh-at-Least-35-kg#:~:text=March%2029%2C%202022%2001%3A30,PM%20Eastern%20Daylight%20Time

Category:  Food,  Medicine Show Health

ViiV Healthcare announces U.S. FDA approval of Dovato …

(Just Now) WebThis is an archived press release which may not reflect current medical knowledge and should not be used as a source of information on the present label, …

https://viivhealthcare.com/en-us/media-center/news/press-releases/2024/april/fda-approval-of-dovato/

Category:  Medical Show Health

ViiV Healthcare to present data for its next generation of ultra long

(9 days ago) WebLONDON, February 28, 2024--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced the …

https://finance.yahoo.com/news/viiv-healthcare-present-data-next-150400807.html

Category:  Health Show Health

ViiV Healthcare to present data for its next generation of ultra long

(3 days ago) WebKey abstracts to be presented at CROI 2024 by ViiV Healthcare and its study partners. examining the safety and tolerability of the highest subcutaneous and …

https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-to-present-data-for-its-next-generation-of-ultra-long-acting-treatments-for-hiv/

Category:  Health Show Health

ViiV Healthcare announces US FDA approval of - Business Wire

(Just Now) WebAbout ViiV Healthcare ViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline (LSE/NYSE: GSK) and Pfizer (NYSE: …

https://www.businesswire.com/news/home/20211220005863/en/ViiV-Healthcare-announces-US-FDA-approval-of-Apretude-cabotegravir-extended-release-injectable-suspension-the-first-and-only-long-acting-injectable-option-for-HIV-prevention

Category:  Health Show Health

ViiV Healthcare Announces US FDA Approval of - Business Wire

(Just Now) WebViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi B.V. as shareholders,

https://www.businesswire.com/news/home/20220329005875/en/ViiV-Healthcare-Announces-US-FDA-Approval-of-Cabenuva-cabotegravir-rilpivirine-for-Virologically-Suppressed-Adolescents-Living-With-HIV-Who-Are-12-Years-of-Age-or-Older-and-Weigh-at-Least-35-kg

Category:  Health Show Health

ViiV Healthcare announces US FDA approval of Cabenuva …

(7 days ago) WebIt contains ViiV Healthcare’s cabotegravir extended-release injectable suspension in a single-dose vial and rilpivirine extended-release injectable suspension in …

https://us.gsk.com/en-us/media/press-releases/viiv-healthcare-announces-us-fda-approval-of-cabenuva-cabotegravir-rilpivirine-for-use-every-two-months-expanding-the-label-of-the-first-and-only-complete-long-acting-hiv-treatment/

Category:  Health Show Health

ViiV Healthcare reports data from injectable HIV treatment trial

(7 days ago) WebFebruary 22, 2024. The trial of the long-acting injectable antiretroviral treatment is underway at 31 sites in the US. Credit: LookerStudio / Shutterstock.com. ViiV Healthcare has …

https://www.clinicaltrialsarena.com/news/viiv-healthcare-hiv-treatment-trial/

Category:  Health Show Health

ViiV Healthcare announces US FDA approval for Rukobia …

(4 days ago) WebViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug …

https://us.gsk.com/en-us/media/press-releases/viiv-healthcare-announces-us-fda-approval-for-rukobia-fostemsavir-a-first-in-class-treatment-for-hiv-in-adults-with-few-treatment-options-available/

Category:  Food Show Health

ViiV Healthcare to present new data from innovative HIV …

(2 days ago) WebAbout ViiV Healthcare. ViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline (LSE: GSK) and Pfizer (NYSE: PFE) …

https://viivhealthcare.com/hiv-news-and-media/news/press-releases/2022/july/viiv-healthcare-to-present-new-data-from-innovative-hiv-treatment/

Category:  Health Show Health

GSK’s ViiV Healthcare to Share Latest Advances in HIV Treatment …

(2 days ago) Web(PRESS RELEASE) LONDON, 19-Oct-2023 — /EuropaWire/ — GSK plc (LSE/NYSE: GSK) announced that ViiV Healthcare, the global specialist HIV company …

https://news.europawire.eu/gsks-viiv-healthcare-to-share-latest-advances-in-hiv-treatment-and-prevention-at-eacs-2023/eu-press-release/2023/10/19/16/52/35/123565/

Category:  Health Show Health

ViiV Healthcare and GSK’s Cabenuva could reduce poor treatment

(6 days ago) WebFollowing the release of positive results for Phase III trial of ViiV Healthcare and GSK’s long-acting injectable antiretroviral treatment (ART) Cabenuva (cabotegravir …

https://www.pharmiweb.com/press-release/2024-02-22/viiv-healthcare-and-gsk-s-cabenuva-could-reduce-poor-treatment-adherence-in-hiv-says-globaldata

Category:  Health Show Health

ViiV Healthcare announces new packaging option now

(3 days ago) WebViiV Healthcare is a global specialist HIV company established in November 2009 by GSK (LSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in …

https://www.businesswire.com/news/home/20240124470296/en/ViiV-Healthcare-announces-new-packaging-option-now-available-in-the-U.S.-for-Dovato-dolutegravirlamivudine

Category:  Health Show Health

ViiV Healthcare announces US FDA approval of Triumeq PD, the …

(2 days ago) WebTo date, there is no established biological mechanism to explain a potential increase in risk. In totality, the available data show inconsistency; therefore, evidence for …

https://us.gsk.com/en-us/media/press-releases/viiv-healthcare-announces-us-fda-approval-of-triumeq-pd-the-first-dispersible-single-tablet-regimen-containing-dolutegravir-a-once-daily-treatment-for-children-living-with-hiv/

Category:  Health Show Health

ViiV Healthcare - Wikipedia

(5 days ago) WebViiV Healthcare (/ ˈ v iː v / VEEV) is a British multinational pharmaceutical company specializing in the research and development of medicines to treat and prevent …

https://en.wikipedia.org/wiki/ViiV_Healthcare

Category:  Medicine Show Health

ViiV Healthcare to present data for its next generation of ultra long

(2 days ago) WebAbout ViiV Healthcare. ViiV Healthcare is a global specialist HIV company established in November 2009 by GSK (LSE: GSK) and Pfizer (NYSE: PFE) dedicated to …

https://us.gsk.com/en-us/media/press-releases/viiv-healthcare-to-present-data-for-its-next-generation-of-ultra-long-acting-treatments-for-hiv/

Category:  Health Show Health

ViiV Healthcare Announces Health Canada Approval for APRETUDE

(5 days ago) WebViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi as shareholders, announced …

https://finance.yahoo.com/news/viiv-healthcare-announces-health-canada-120100247.html

Category:  Health Show Health

ViiV Healthcare announces label update for its long-acting HIV

(8 days ago) WebAbout ViiV Healthcare. ViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline (LSE: GSK) and Pfizer (NYSE: PFE) …

https://us.gsk.com/en-us/media/press-releases/viiv-healthcare-announces-label-update-for-its-long-acting-hiv-treatment-cabenuva-cabotegravir-rilpivirine-to-be-initiated-with-or-without-an-oral-lead-in-period/

Category:  Health Show Health

ViiV Healthcare to present data for its next generation of ultra long

(7 days ago) WebViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced the presentation of 64 …

https://www.morningstar.com/news/business-wire/20240223777191/viiv-healthcare-to-present-data-for-its-next-generation-of-ultra-long-acting-treatments-for-hiv

Category:  Health Show Health

Our History & Mission ViiV Healthcare US

(4 days ago) WebThis is an archived press release which may not reflect current medical knowledge and should not be used as a source of information on the present label, safety data or …

https://viivhealthcare.com/en-us/about-viiv/history-and-mission/

Category:  Medical Show Health

Filter Type: